T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 151–200 of 404 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05885464	A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)	active not recruiting	Phase 1 / Phase 2	5	Beam Therapeutics Inc.INDUSTRY	1	Jan 13, 2025	clinicaltrials
NCT04502446	A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)	terminated	Phase 1	49	CRISPR Therapeutics AGINDUSTRY	3	Jan 8, 2025